MFSL
Life InsuranceMax Financial Services Limited
MFSL or Max India was incorporated in 1988, and it is a multi-business enterprise. Also, the company has a business interest in the sectors of life insurance, healthcare, and clinical research.
Also, the company has subsidiaries such as Max New York Life - a joint venture between Max India and New York Life; and Max Healthcare – that is engaged in providing healthcare services; and Max Bupa Health Insurance, which is a joint venture between Max India and Bupa Finance Plc. Also, the UK involved in the clinical research business and the Max Neeman – a manufacturer of specialty products for the industry of packaging.
The Company also operates via 555 offices across more than 364 locations in the country. The company has an employee strength of approximately 92,000 people. It also has various divisions that have received ISO 9001:2000 and IS014001: 2004 certifications for their quality management.
Earlier, the company had a business interest in several sectors of electronic component distribution, plating the chemicals, and penicillin-based bulk drugs and also the generic bulk drugs. But, later the company divested its business interests in such businesses.
Max New York Life (MNYL) – Under this segment, the company has a joint venture between Max India and New York Life and was incorporated in the year 2000. Also, the company offers a spectrum of products in both individual and group life insurance solutions. Currently, it is among the leading private sector life insurance industries.
Max Healthcare (MHC) – Under this segment, the company has a division that operates in 8 hospitals located in both Delhi and NCR. Such hospitals offer services in the area of orthopedics and joint replacement, pediatrics, neurosciences, obstetrics and gynecology, aesthetic and reconstructive plastic surgery and internal medicine.
- Trades at a P/E of 105, with a return on equity (ROE) of 9.21%.
- MFSL is trading below all of its key moving averages (10/20/50/100/200-DMA) — a bearish technical setup.
- Year-to-date it is down 9.65%, and down 10.38% over the past year.
- At ₹1,492.90 it sits about 13% of the way up its 52-week range (₹1,433.60–₹1,892.50).
- Market capitalisation stands at ₹51,557 Cr.
Shareholding data syncs daily.
| Year | Revenue | Net Profit | EPS | NPM |
|---|---|---|---|---|
| Mar 2023 | ₹58 Cr | ₹14 Cr | ₹0.40 | 24.14% |
| Mar 2022 | ₹200 Cr | ₹103 Cr | ₹2.97 | 51.5% |
| Mar 2021 | ₹31,275 Cr | ₹425 Cr | ₹12.33 | 1.36% |
| Mar 2021 | ₹31,275 Cr | ₹425 Cr | ₹12.33 | 1.36% |
| Mar 2020 | ₹18,240 Cr | ₹145 Cr | ₹5.38 | 0.79% |
| Mar 2020 | ₹18,240 Cr | ₹145 Cr | ₹5.38 | 0.79% |
| Mar 2019 | ₹19,498 Cr | ₹263 Cr | ₹9.75 | 1.35% |
| Mar 2019 | ₹19,498 Cr | ₹263 Cr | ₹9.75 | 1.35% |
| Mar 2018 | ₹16,338 Cr | ₹286 Cr | ₹10.67 | 1.75% |
| Mar 2017 | ₹15,247 Cr | ₹395 Cr | ₹14.79 | 2.59% |
| Mar 2016 | ₹11,710 Cr | ₹253 Cr | ₹7.57 | 2.16% |
| Mar 2015 | ₹14,907 Cr | ₹280 Cr | ₹8.96 | 1.88% |
| Company | P/E | Book Value | Sales Growth |
|---|---|---|---|
| HDFCLIFE HDFC Life Insurance Company Ltd | 87.38 | ₹31.48 | 28.36% |
| SBILIFE SBI Life Insurance Company Ltd | 67.52 | ₹84.85 | 32.16% |
| ICICIPRULI ICICI Prudential Life Insurance Company Ltd | 59.56 | ₹52.36 | 25.76% |
| Date | Client | Type | Qty | Price |
|---|---|---|---|---|
| 29 Mar 2023 | MAX VENTURES INVESTMENT HOLDINGS PRIVATE LIMITED | SALE | 30,00,000 | ₹606.60 |
| 29 Mar 2023 | PLUTUS WEALTH MANAGEMENT LLP | PURCHASE | 20,00,000 | ₹606.60 |
| 29 Mar 2023 | MAX VENTURES INVESTMENT HOLDINGS PRIVATE LIMITED | SALE | 10,00,000 | ₹606.60 |
| 29 Mar 2023 | MAX VENTURES INVESTMENT HOLDINGS PRIVATE LIMITED | SALE | 20,00,000 | ₹606.60 |
| 29 Mar 2023 | PLUTUS WEALTH MANAGEMENT LLP | PURCHASE | 10,00,000 | ₹606.60 |
| 29 Mar 2023 | PLUTUS WEALTH MANAGEMENT LLP | PURCHASE | 20,00,000 | ₹606.60 |
| 03 Nov 2022 | ISHARES CORE EMERGING MARKETS MAURITIUS CO | SALE | 3,41,721 | ₹720.45 |
| 03 Nov 2022 | ISHARES CORE MSCI EMERGING MARKETS ETF | PURCHASE | 3,41,721 | ₹720.45 |
| 25 Oct 2022 | ISHARES CORE EMERGING MARKETS MAURITIUS CO | SALE | 1,83,846 | ₹698.80 |
| 25 Oct 2022 | ISHARES CORE MSCI EMERGING MARKETS ETF | PURCHASE | 1,83,846 | ₹698.80 |
| 25 Oct 2022 | ISHARES INDIA SC MAURITIUS COMPANY | SALE | 1,34,881 | ₹698.80 |
| 25 Oct 2022 | ISHARES MSCI INDIA SMALL-CAP ETF | PURCHASE | 1,34,881 | ₹698.80 |
Fundamentals, financials & technicals sourced from niftytrader.in, cached and refreshed periodically.